Information  X 
Enter a valid email address

Zoetic Interntnl PLC (ZOE)

  Print   

Tuesday 01 June, 2021

Zoetic Interntnl PLC

Issue of Warrants

RNS Number : 2833A
Zoetic International PLC
01 June 2021
 

 

 

 

1 June 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

Zoetic International plc

('Zoetic' or the 'Group')

 

Issue of Warrants

 

Zoetic, the international CBD group, announces that it has issued 1,200,000 warrants to subscribe for new ordinary shares of 1 pence each ("Ordinary Shares") at 60 pence per new Ordinary Share at any point until 1 May 2026 (the "Warrants").  The Warrants are being issued by Zoetic to a consultant to the Company in consideration for services rendered.  The Warrants will not be listed on any exchange.

 

 

- Ends -

 

Publication on website

 

A copy of this announcement is also available on the Group's website at www.zoeticinternational.com

 

Media enquiries:

 

Zoetic International plc

 

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

 

Allenby Capital Limited (Financial Adviser and Broker)

 

+44 (0) 20 3328 5656

Nick Harriss/Nick Naylor (Corporate Finance)

 

 

Kelly Gardiner (Equity Sales)

 

 

 

Buchanan

 

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

 

Tel: +44 (0) 20 7466 5000

[email protected]

 

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGZGFKZGMGMZM

a d v e r t i s e m e n t